Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.
about
Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cellsFabrication, characterization, and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted photochemotherapy of breast cancer cellsSynthesis, characterization, and biological verification of anti-HER2 indocyanine green-doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for targeted photochemotherapy of breast cancer cellsAccelerator mass spectrometry-enabled studies: current status and future prospects.Doxorubicin, DNA torsion, and chromatin dynamics.A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissuesRecent advances in biomedical applications of accelerator mass spectrometry.CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.Sources of extracellular, oxidatively-modified DNA lesions: implications for their measurement in urine.Furan carcinogenicity: DNA binding and genotoxicity of furan in rats in vivo.Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53.The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts.Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism.Interaction of anthraquinones of Cassia occidentalis seeds with DNA and Glutathione.Interaction of Calf Thymus DNA with the Ni(II) Complex of Sodium 1,4-Dihydroxy-9,10-Anthraquinone-2-Sulphonate: A Novel Method of Analysis Using Cyclic Voltammetry
P2860
Q28486164-952DFB69-F9A6-4D24-B686-232E64BA2DE0Q33587331-70ABAE55-C43D-4193-B518-4DD25456B23DQ33706296-DFD41553-A51F-4845-9AE9-196F9C37AC53Q33819361-152821FE-C69A-4773-B57C-9E757AD1F517Q34039414-98AEAC0A-B759-4C9C-927E-185AEAB7E91AQ36435596-72DDF74C-3895-44B7-AA19-679E86C27D56Q37266360-18A45868-8EDA-4D03-A85E-0D5E7BF4491DQ37406076-CB82B3A6-BE48-4FB3-B617-E89A808DBA0BQ37407483-0A2EAA8C-88D3-47B0-A1E8-655573331795Q37480300-814FB278-A71B-4D26-94DB-B25936B0DD78Q38809821-E6837347-E3C2-420C-A0CB-CEB2CBE02566Q39221670-0DFEC250-5FC1-45FE-9FF8-329A333BD286Q39737530-49B663D0-FE74-4309-B1C6-CC1AE2765EF9Q49404929-CF9D3F5F-4634-4765-966F-8F3DD8C30AB8Q58703446-B1BE4906-EF15-405D-AE5E-E1692F66CC1D
P2860
Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Detection of Adriamycin-DNA ad ...... ant Adriamycin concentrations.
@en
type
label
Detection of Adriamycin-DNA ad ...... ant Adriamycin concentrations.
@en
prefLabel
Detection of Adriamycin-DNA ad ...... ant Adriamycin concentrations.
@en
P2093
P2860
P356
P1476
Detection of Adriamycin-DNA ad ...... ant Adriamycin concentrations.
@en
P2093
Don R Phillips
Kate E Coldwell
Paul T Henderson
Ted J Ognibene
P2860
P356
10.1093/NAR/GKN439
P407
P577
2008-07-16T00:00:00Z